Scientific American: Oncologists wrestle with COVID-19 pandemic's effect on cancer
UC expert details how pause in lung cancer screening affected patient outcomes
As we near the two-year mark of when the COVID-19 pandemic caused shutdowns and canceled many elective procedures, oncologists across the country continue to examine how this pause in cancer screenings is affecting patients.
Robert Van Haren, MD, said after the lung cancer screening program at UC was closed for about three months in early 2020, doctors found many more suspicious nodules on the lungs compared to usual once screening resumed.
"Even small changes in the size of a lung cancer can be important for overall survival,” Van Haren, assistant professor of surgery in the Division of Thoracic Surgery in UC’s College of Medicine, a UC Health thoracic surgeon and University of Cincinnati Cancer Center member, told Scientific American. “That’s the reason we’re concerned about any delays or stoppages.”
Read the Scientific American article.
Featured photo of Robert Van Haren, MD. Photo/Colleen Kelley/University of Cincinnati.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.